Staff Scientist (Senior Manager), Quality Control & Analytical Development at Glyphic Biotechnologies

Berkeley, California, United States

Apply Now

$146,000 – $213,000Compensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Strong background in analytical chemistry
Experience operating and troubleshooting LCMS and HPLC systems
Expertise in method development, data interpretation, and regulatory compliance
Hands-on experience with protein and nucleic acid characterization and purity assessment
Experience with in-line quality control processes and monitoring programs
Familiarity with stability studies and comparability programs
Ability to work effectively with a cross-disciplinary team (chemists, biologists, engineers, and bio-informaticians)

Responsibilities

Execute analytical testing using LCMS, HPLC, and CE instruments for protein and nucleic acid characterization and purity assessment
Establish and operate a new QC & AD core to support instrument and assay development
Develop, optimize, and validate analytical methods to characterize novel protein sequencing instrumentation and production processes
Implement and oversee phase-appropriate in-line quality control processes and monitoring programs
Establish and perform QC testing for raw materials and finished products
Support investigations for out-of-specification results, including root cause analysis, corrective action implementation, and detailed investigation reports
Support stability studies and comparability programs
Establish and maintain a phase-appropriate environmental monitoring program
Generate quality metrics reports analyzing testing volumes, turnaround times, and trends in analytical results
Manage QC sample storage, retention, and disposal according to safety protocols

Skills

LCMS

HPLC

analytical chemistry

method development

method validation

data interpretation

regulatory compliance

protein characterization

nucleic acid characterization

purity assessment

stability studies

comparability programs

QC testing

Glyphic Biotechnologies

Develops next-generation protein sequencing platform

About Glyphic Biotechnologies

Glyphic Biotechnologies focuses on advancing the field of proteomics by developing a unique protein sequencing platform. This platform enables researchers to analyze proteins in detail, which helps them understand biological processes and diseases better. The technology works by providing advanced sequencing services that allow for in-depth study of protein structures and functions. Unlike other companies in the biotechnology sector, Glyphic Biotechnologies emphasizes a next-generation approach to protein sequencing, aiming to deliver insights that are not available through traditional methods. The company's goal is to enhance biological and medical research by providing tools that facilitate a deeper understanding of proteins and their roles in health and disease.

New York City, New YorkHeadquarters

2021Year Founded

$41.9MTotal Funding

EARLY_VCCompany Stage

Biotechnology, HealthcareIndustries

11-50Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Unlimited Paid Time Off

Commuter Benefits

Paid Maternity and Paternity Leave

Home Office Stipend

Wellness Program

Company Equity

Employee Stock Purchase Plan

Risks

Intellectual property disputes may arise in the competitive biotechnology sector.

Dependence on external funding poses financial risks if sources become insufficient.

Rapid technological advancements may render Glyphic's platform obsolete if not updated.

Differentiation

Glyphic's platform uses single-molecule technology for precise protein sequencing.

The company accelerates protein sequencing, reducing drug development times significantly.

Glyphic's technology surpasses mass spectrometry in analyzing complex protein mixtures.

Upsides

The proteomics market is projected to grow at a CAGR of 14.7% until 2030.

Glyphic received a $409K SBIR grant from NIH for its innovative technology.

Increased interest in single-molecule protein sequencing indicates potential collaborations.

Land your dream remote job 3x faster with AI

Try Jobo Free